Therapeutics and microbiota

Microb Health Dis 2022; 4: e762
DOI: 10.26355/mhd_20229_762

  Topic: Microbiota     Category:

Abstract

The gut microbiota is considered an essential “organ” due to its various functions and significance for human health, and its altered composition and function have been linked with various disease states of the host. Over the years, different strategies aimed at targeting the gut microbiota have emerged as promising tools for the prevention and management of several human disorders. This review summarizes notable findings from studies published between April 2021 and March 2022 evaluating the therapeutic potential of microbiota-modulatory agents, including prebiotics, probiotics, and synbiotics in intestinal and cardiometabolic diseases.

To cite this article

Therapeutics and microbiota

Microb Health Dis 2022; 4: e762
DOI: 10.26355/mhd_20229_762

Publication History

Submission date: 27 May 2022

Revised on: 27 May 2022

Accepted on: 08 Jun 2022

Published online: 20 Sep 2022